The European Association for Cancer Research
Advancing cancer research - from basic research to prevention, treatment and care
Contact us
Please contact us using the form below or email eacr@nottingham.ac.uk
Alternatively our contact details are
 |
 |
|
Andrew Binns New applications, Website & General enquiries |
Kathryn Wass Meetings, Advertising & Fellowships |
|
EACR Secretariat, |
Tel: +44 115 951 5116 |
Members' Log in
Latest News
EACR Members’ Survey 2008
If you missed the e-mail asking you to complete the 2008 EACR Members’ Survey, please visit the ‘View newsletters and publications’ page in the Members Area where there is a link to the questionnaire.
EACR-20 Registration - Members Late-Rate open until 2 June 2008
Registration is now open for EACR-20 with an excellent ‘late-rate’ for EACR Members. Late Rate payments must be made before 2 June 2008.
Keep contact details up to date to receive regular EACR news by e-mail and air-mail
Members' Items
How to apply for a Meeting Bursary to attend EACR-20
Meeting Bursary applications will be evaluated on 23 April 2008 and all applicants will be notified as soon as possible around the middle of May 2008.
Jobs and Study Opportunities
Postdoctoral position available
The package includes a competitive salary 36.000 euros/year, managerial and scientific training and a number of benefits.
IFOM-IEO Campus, Milan, Italy
For further information >Cancer Research Opportunities at IRCC (Italy) for post-docs and a junior P.I.
The Division of Molecular Oncology at the Institute for Cancer Research and Treatment (IRCC) invites applications for three post-doctoral positions, to study the function of Met and the semaphorins in cancer progression, with particular interest for identifying the implicated molecular mechanisms and developing molecular tools to target these pathways in human tumors. In addition, we welcome applications for one tenure-track position reserved to young independent investigators, with outstanding qualification in this field.
Post-Doctoral Position, The Immunotherapy & Gene Therapy Unit
The Immunotherapy & Gene Therapy Unit seeks a candidate with experience in immunology to study regulatory T cells expansion, conversion and inactivation in tumor bearers using a variety of mixed bone marrow chimeras as well as gene shut down in bone marrow donors.